Experienced in Chronic Inflammatory Demyelinating Polyneuropathy

Hacer I. Durmus

Istanbul, TR 
Experienced in Chronic Inflammatory Demyelinating Polyneuropathy
Istanbul, TR 
OverviewLocationsClinical Research

Overview

Hacer Durmus practices in Istanbul, Turkey. Durmus is rated as an Experienced expert by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. Their top areas of expertise are Congenital Myasthenic Syndrome, Myasthenia Gravis, Primary Lateral Sclerosis, and Glycogen Storage Disease Type 5.

Their clinical research consists of co-authoring 66 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chronic Inflammatory Demyelinating Polyneuropathy.

Locations

Istanbul, 34093, Turkey
Other Locations
Capa, 34390, Turkey
Fatih, 34104, Turkey
Kutahya, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency Treated With the Combination of Pyrimidine Nucleos(t)Ides as Well as Untreated Subjects to Collect Vital Status Data and Supporting Information
A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency Treated With the Combination of Pyrimidine Nucleos(t)Ides as Well as Untreated Subjects to Collect Vital Status Data and Supporting Information
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Other
View 1 Less Clinical Trial

66 Total Publications

The Effect of Aerobic Exercise Training on Patients with Type III Spinal Muscular Atrophy.
The Effect of Aerobic Exercise Training on Patients with Type III Spinal Muscular Atrophy.
Journal: Journal of clinical medicine
Published: June 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Durmus's expertise for a condition
ConditionClose
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile